Canakinumab
CAS: 914613-48-2
Ref. TM-T73695
1mg | 443.00 € | ||
2mg | 624.00 € | ||
5mg | 936.00 € | ||
10mg | 1,254.00 € | ||
25mg | 1,867.00 € | ||
50mg | 2,526.00 € | ||
100mg | 3,412.00 € |
Product Information
- ACZ 885, Ilaris
Canakinumab (ACZ885) is a recombinant human IL-1β-targeting monoclonal antibody.Canakinumab has been shown to inhibit human and chorioallantoic monkey IL-1β, with IC50 values of 43.6 and 40.8 pM, respectively.Canakinumab has anti-inflammatory activity, inhibiting inflammation associated with autoimmune diseases by neutralizing IL-1β signaling. Canakinumab has anti-inflammatory activity, inhibiting inflammation associated with autoimmune diseases by neutralizing IL-1β signaling.Canakinumab has been used for the treatment of gout and coronary artery disease.
Chemical properties
Technical inquiry about: TM-T73695 Canakinumab
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.